A Benefit to Add-On Abemaciclib in Advanced Breast Cancer?

Adding abemaciclib to an aromatase inhibitor improved overall survival in HR+/HER2− advanced breast cancer, but the benefit was not statistically significant, according to final trial results.
Medscape Medical News